Market Overview:
The global Fletcher Factor Assay market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of thrombotic disorders, rising demand for point-of-care testing, and technological advancements in Fletcher Factor Assay products. Based on type, the global Fletcher Factor Assay market is segmented into prolonged activated partial thromboplastin time test (APTT) and high-molecular weight kininogen (HMWK) deficiency. The APTT segment is expected to account for the majority share of the global Fletcher Factor Assay market in 2018 owing to its widespread use for diagnosis of various thrombotic disorders. By application, the hospital segment is expected to account for a major share of the global Fletcher Factor Assay market in 2018 due to increasing demand for point-of-care testing from hospitals worldwide. Geographically, North America dominates the global Fletcher Factor Assay market followed by Europe and Asia Pacific respectively.
Product Definition:
A Fletcher Factor Assay is a blood test used to measure the number of white blood cells in the bloodstream. This test is important because it can help doctors diagnose and monitor conditions that affect the number of white blood cells in the body, such as leukemia and other types of cancer.
Prolonged Activated Partial Thromboplastin Time Test (APTT):
The Prolonged Activated Partial Thromboplastin Time (APTT) test is used to measure the time taken for blood coagulation factors to clot. This test is also known as Fibrinolytic assay and helps evaluate the effectiveness of anticoagulants used in patients with cardiovascular diseases.
High-Molecular Weight Kininogen (HMWK) Deficiency:
HMWK (high-molecular weight kininogen) deficiency is an autosomal recessive disorder affecting the kidney and liver. The disease has a prevalence of 1 in 100,000 to 1 in 10,000 individuals.
Application Insights:
The hospital application segment led the market in 2017 and is projected to expand at a revenue-based CAGR of XX% over the forecast period. The factor deficiency has been recognized as one of the major causes of bleeding in patients with hemophilia, which requires immediate treatment and can be life-threatening if not treated within a reasonable time. Thus, increasing number of hospital admissions for conditions such as trauma, burns, or surgeries requiring blood transfusion are expected to drive demand for these tests during the forecast period.
In addition, growing awareness about factor deficiencies among individuals above 40 years old is anticipated to fuel demand for diagnostic centers over the forecast period due to increase incidence rate of hip fractures coupled with rising geriatric population across various regions including North America.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high adoption rate for technologically advanced products are some factors contributing to the growth of this region. Moreover, increasing incidence of venous disorders such as varicose veins & spider veins along with rising number of surgeries due to these conditions is expected to drive the regional demand for blood clotting factor assays during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving healthcare facilities and growing awareness regarding VTE diagnosis & treatment in emerging countries such as China & India. In addition, favorable government initiatives aimed at promoting quality medical care are likely boost product demand in this region over next eight years. Europe accounted for a significant share owing to its well-developed primary care system coupled with local presence of major companies that manufacture diagnostic tests relatedto blood clotting factors including prothrombin complex concentrate (PCC) and thrombin time test (TT).
Growth Factors:
- Increasing prevalence of cancer: The incidence of cancer is increasing at an alarming rate across the globe. This is primarily attributed to the changing lifestyle and dietary habits of people. According to a study by the World Health Organization (WHO), the number of new cancer cases is expected to rise from 14 million in 2012 to 22 million by 2030. This will create a large pool of patients who will require diagnosis and treatment, thereby driving demand for Fletcher Factor Assay products and services.
- Technological advancements: The field of diagnostics is witnessing rapid advancements with respect to technology, which is helping researchers develop better diagnostic tests for various diseases including cancer. Fletcher Factor Assay products are benefiting from these technological advances as they are becoming more accurate and efficient in detecting early-stage cancers. This is likely to fuel demand for these products in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Fletcher Factor Assay Market Research Report
By Type
Prolonged Activated Partial Thromboplastin Time Test (APTT), High-Molecular Weight Kininogen (HMWK) Deficiency
By Application
Hospital, Diagnostic Center, Specialty Clinic
By Companies
Pathway Diagnostics, Bio-Rad Laboratories, ARUP Laboratories, Leica Biosystems, Abbott Molecular Inc, Innovative Research, Assaypro
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Fletcher Factor Assay Market Report Segments:
The global Fletcher Factor Assay market is segmented on the basis of:
Types
Prolonged Activated Partial Thromboplastin Time Test (APTT), High-Molecular Weight Kininogen (HMWK) Deficiency
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Diagnostic Center, Specialty Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pathway Diagnostics
- Bio-Rad Laboratories
- ARUP Laboratories
- Leica Biosystems
- Abbott Molecular Inc
- Innovative Research
- Assaypro
Highlights of The Fletcher Factor Assay Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prolonged Activated Partial Thromboplastin Time Test (APTT)
- High-Molecular Weight Kininogen (HMWK) Deficiency
- By Application:
- Hospital
- Diagnostic Center
- Specialty Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fletcher Factor Assay Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Fletcher factor assay is a method used to measure the binding of a ligand to its receptor. The ligand is mixed with the receptor in solution and then incubated at different temperatures. The amount of bound ligand can be determined by measuring the change in absorbance at 280 nm.
Some of the key players operating in the fletcher factor assay market are Pathway Diagnostics, Bio-Rad Laboratories, ARUP Laboratories, Leica Biosystems, Abbott Molecular Inc, Innovative Research, Assaypro.
The fletcher factor assay market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Fletcher Factor Assay Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Fletcher Factor Assay Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Fletcher Factor Assay Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Fletcher Factor Assay Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Fletcher Factor Assay Market Size & Forecast, 2018-2028
4.5.1 Fletcher Factor Assay Market Size and Y-o-Y Growth
4.5.2 Fletcher Factor Assay Market Absolute $ Opportunity
Chapter 5 Global Fletcher Factor Assay Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Fletcher Factor Assay Market Size Forecast by Type
5.2.1 Prolonged Activated Partial Thromboplastin Time Test (APTT)
5.2.2 High-Molecular Weight Kininogen (HMWK) Deficiency
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Fletcher Factor Assay Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Fletcher Factor Assay Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Diagnostic Center
6.2.3 Specialty Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Fletcher Factor Assay Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Fletcher Factor Assay Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Fletcher Factor Assay Analysis and Forecast
9.1 Introduction
9.2 North America Fletcher Factor Assay Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Fletcher Factor Assay Market Size Forecast by Type
9.6.1 Prolonged Activated Partial Thromboplastin Time Test (APTT)
9.6.2 High-Molecular Weight Kininogen (HMWK) Deficiency
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Fletcher Factor Assay Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Diagnostic Center
9.10.3 Specialty Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Fletcher Factor Assay Analysis and Forecast
10.1 Introduction
10.2 Europe Fletcher Factor Assay Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Fletcher Factor Assay Market Size Forecast by Type
10.6.1 Prolonged Activated Partial Thromboplastin Time Test (APTT)
10.6.2 High-Molecular Weight Kininogen (HMWK) Deficiency
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Fletcher Factor Assay Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Diagnostic Center
10.10.3 Specialty Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Fletcher Factor Assay Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Fletcher Factor Assay Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Fletcher Factor Assay Market Size Forecast by Type
11.6.1 Prolonged Activated Partial Thromboplastin Time Test (APTT)
11.6.2 High-Molecular Weight Kininogen (HMWK) Deficiency
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Fletcher Factor Assay Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Diagnostic Center
11.10.3 Specialty Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Fletcher Factor Assay Analysis and Forecast
12.1 Introduction
12.2 Latin America Fletcher Factor Assay Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Fletcher Factor Assay Market Size Forecast by Type
12.6.1 Prolonged Activated Partial Thromboplastin Time Test (APTT)
12.6.2 High-Molecular Weight Kininogen (HMWK) Deficiency
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Fletcher Factor Assay Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Diagnostic Center
12.10.3 Specialty Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Fletcher Factor Assay Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Fletcher Factor Assay Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Fletcher Factor Assay Market Size Forecast by Type
13.6.1 Prolonged Activated Partial Thromboplastin Time Test (APTT)
13.6.2 High-Molecular Weight Kininogen (HMWK) Deficiency
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Fletcher Factor Assay Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Diagnostic Center
13.10.3 Specialty Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Fletcher Factor Assay Market: Competitive Dashboard
14.2 Global Fletcher Factor Assay Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pathway Diagnostics
14.3.2 Bio-Rad Laboratories
14.3.3 ARUP Laboratories
14.3.4 Leica Biosystems
14.3.5 Abbott Molecular Inc
14.3.6 Innovative Research
14.3.7 Assaypro
